Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Search content at Experts@Minnesota
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
Fecal hydrogen sulfide production in ulcerative colitis
Jimmy Levine
, Carol J. Ellis
, Julie K. Furne
, John Springfield
, Michael D. Levitt
Research output
:
Contribution to journal
›
Article
›
peer-review
198
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Fecal hydrogen sulfide production in ulcerative colitis'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Ulcerative Colitis
100%
Hydrogen Sulfide Production
100%
Feces
85%
Sulfide
42%
Sulfate-reducing Bacteria
28%
H2S Release
28%
Mucin
14%
Organic Compounds
14%
Cysteine
14%
Fecal Samples
14%
Methanethiol
14%
Dimethyl Sulfide
14%
Substrate Availability
14%
Taurocholate
14%
Fecal Bacteria
14%
H2S Production
14%
Gas Release
14%
CO2 Release
14%
4-fold
14%
Metabolic Aberration
14%
Rising CO2
14%
Surrounding Gas
14%
Sulfur-containing Substrate
14%
Medicine and Dentistry
Ulcerative Colitis
100%
Hydrogen Sulfide
100%
Feces
85%
Sulfate
42%
Sulfide
42%
Bacterium
42%
Carbon Dioxide
28%
Supplementation
14%
Methane
14%
Mucin
14%
Cysteine
14%
Taurocholic Acid
14%
Methanethiol
14%
Dimethyl Sulfide
14%
Organic Compound
14%
Pharmacology, Toxicology and Pharmaceutical Science
Hydrogen Sulfide
100%
Ulcerative Colitis
100%
Sulfide
42%
Thioether
42%
Sulfate Reducing Bacterium
28%
Carbon Dioxide
28%
Feces microflora
14%
Dimethyl Sulfide
14%
Methane
14%
Mucin
14%
Cysteine
14%
Methanethiol
14%
Taurocholic Acid
14%
Sulfate
14%
Organic Compound
14%